Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.
about
Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.Systematic review and meta-analyses of the effect of chemotherapy on pulmonary Mycobacterium abscessus outcomes and disease recurrence.A programme to create short-course chemotherapy for pulmonary Mycobacterium avium disease based on pharmacokinetics/pharmacodynamics and mathematical forecasting.New insights in the treatment of nontuberculous mycobacterial pulmonary disease.Mycobacterium abscessus Smooth And Rough Morpohotypes Form Antimicrobial-Tolerant Biofilm Phenotypes But Are Killed by Acetic Acid.NTM drug discovery: status, gaps and the way forward.
P2860
Moxifloxacin's Limited Efficacy in the Hollow-Fiber Model of Mycobacterium abscessus Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Moxifloxacin's Limited Efficac ...... cobacterium abscessus Disease.
@en
type
label
Moxifloxacin's Limited Efficac ...... cobacterium abscessus Disease.
@en
prefLabel
Moxifloxacin's Limited Efficac ...... cobacterium abscessus Disease.
@en
P2860
P50
P356
P1476
Moxifloxacin's Limited Efficac ...... cobacterium abscessus Disease.
@en
P2093
Devyani Deshpande
Jotam G Pasipanodya
P2860
P304
P356
10.1128/AAC.02821-15
P407
P577
2016-04-11T00:00:00Z